291 related articles for article (PubMed ID: 36395610)
1. Metabolic reprogramming of immune cells in pancreatic cancer progression.
Xiang H; Yang R; Tu J; Xi Y; Yang S; Lv L; Zhai X; Zhu Y; Dong D; Tao X
Biomed Pharmacother; 2023 Jan; 157():113992. PubMed ID: 36395610
[TBL] [Abstract][Full Text] [Related]
2. Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer.
Guo D; Ye L; Wu W; Yu X; Jin K
Acta Biochim Biophys Sin (Shanghai); 2023 Apr; 55(6):923-937. PubMed ID: 37021976
[TBL] [Abstract][Full Text] [Related]
3. Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin.
Bahrambeigi S; Shafiei-Irannejad V
Biochem Pharmacol; 2020 Apr; 174():113787. PubMed ID: 31884044
[TBL] [Abstract][Full Text] [Related]
4. mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment.
Mafi S; Mansoori B; Taeb S; Sadeghi H; Abbasi R; Cho WC; Rostamzadeh D
Front Immunol; 2021; 12():774103. PubMed ID: 35250965
[TBL] [Abstract][Full Text] [Related]
5. PI3K signaling-regulated metabolic reprogramming: From mechanism to application.
Su WY; Tian LY; Guo LP; Huang LQ; Gao WY
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188952. PubMed ID: 37499988
[TBL] [Abstract][Full Text] [Related]
6. Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more.
Hao X; Ren Y; Feng M; Wang Q; Wang Y
Biomed Pharmacother; 2021 Sep; 141():111798. PubMed ID: 34120068
[TBL] [Abstract][Full Text] [Related]
7. Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy.
Yan L; Tan Y; Chen G; Fan J; Zhang J
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638609
[TBL] [Abstract][Full Text] [Related]
8. Metabolic reprogramming of macrophages during infections and cancer.
Wang S; Liu R; Yu Q; Dong L; Bi Y; Liu G
Cancer Lett; 2019 Jun; 452():14-22. PubMed ID: 30905817
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic metabolic reprogramming in breast cancer: focus on signaling pathways and mitochondrial genes.
Malayil R; Chhichholiya Y; Vasudeva K; Singh HV; Singh T; Singh S; Munshi A
Med Oncol; 2023 May; 40(6):174. PubMed ID: 37170010
[TBL] [Abstract][Full Text] [Related]
10. Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy.
Li M; Li M; Yang Y; Liu Y; Xie H; Yu Q; Tian L; Tang X; Ren K; Li J; Zhang Z; He Q
J Control Release; 2020 May; 321():23-35. PubMed ID: 32035193
[TBL] [Abstract][Full Text] [Related]
11. Immunometabolism: A new target for improving cancer immunotherapy.
Guo C; Chen S; Liu W; Ma Y; Li J; Fisher PB; Fang X; Wang XY
Adv Cancer Res; 2019; 143():195-253. PubMed ID: 31202359
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic regulation of tumor metabolic reprogramming.
Tarrado-Castellarnau M; de Atauri P; Cascante M
Oncotarget; 2016 Sep; 7(38):62726-62753. PubMed ID: 28040803
[TBL] [Abstract][Full Text] [Related]
13. Tumor Cell-Intrinsic SETD2 Deficiency Reprograms Neutrophils to Foster Immune Escape in Pancreatic Tumorigenesis.
Niu N; Shen X; Zhang L; Chen Y; Lu P; Yang W; Liu M; Shi J; Xu D; Tang Y; Yang X; Weng Y; Zhao X; Wu LM; Sun Y; Xue J
Adv Sci (Weinh); 2023 Jan; 10(2):e2202937. PubMed ID: 36453584
[TBL] [Abstract][Full Text] [Related]
14. Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor.
Yan D; Adeshakin AO; Xu M; Afolabi LO; Zhang G; Chen YH; Wan X
Front Immunol; 2019; 10():1399. PubMed ID: 31275326
[TBL] [Abstract][Full Text] [Related]
15. Targeting mTOR and Metabolism in Cancer: Lessons and Innovations.
Magaway C; Kim E; Jacinto E
Cells; 2019 Dec; 8(12):. PubMed ID: 31817676
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Reprogramming of Myeloid-derived Suppressor Cells in the Tumor Microenvironment.
Liu L; Huo S; Liu J; Li Q; Wang J
Discov Med; 2021; 31(164):141-146. PubMed ID: 35188888
[TBL] [Abstract][Full Text] [Related]
17. Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.
Fan C; Zhang S; Gong Z; Li X; Xiang B; Deng H; Zhou M; Li G; Li Y; Xiong W; Zeng Z; Li X
Sci China Life Sci; 2021 Apr; 64(4):534-547. PubMed ID: 32815067
[TBL] [Abstract][Full Text] [Related]
18. Emerging roles of non-coding RNAs in the metabolic reprogramming of tumor-associated macrophages.
Li J; Lu Z; Zhang Y; Xia L; Su Z
Immunol Lett; 2021 Apr; 232():27-34. PubMed ID: 33577913
[TBL] [Abstract][Full Text] [Related]
19. The Unfolded Protein Response Plays a Predominant Homeostatic Role in Response to Mitochondrial Stress in Pancreatic Stellate Cells.
Su HY; Waldron RT; Gong R; Ramanujan VK; Pandol SJ; Lugea A
PLoS One; 2016; 11(2):e0148999. PubMed ID: 26849807
[TBL] [Abstract][Full Text] [Related]
20. Nano-realgar suppresses lung cancer stem cell growth by repressing metabolic reprogramming.
Yang FR; Zhao YF; Hu XW; Liu ZK; Yu XD; Li CY; Li XR; Li HJ
Gene; 2021 Jul; 788():145666. PubMed ID: 33887368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
